Me Holding Co. secured bankruptcy court approval to sell its genetic data trove to its co-founder and a related nonprofit for ...

In January of 2024, the class action lawsuit was filed against the company, alleging that 23andMe failed to protect the data ...

The clock is ticking and you only have a few weeks left to file a claim and get part of the 23andMe class-action settlement.

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Westlake and Ascend close plants, Chemify opens AI-robotics lab, Formation licenses gusacitinib to Sanofi, and more ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

A lawsuit against the genomics company "imposes top-down restrictions" rather than "establishing clear rules" or "letting ...

The National Weather Service issued the heat advisory earlier this week, with temperatures in central Alaska climbing to the ...

UBS has decided Regeneron Pharmaceuticals needs a new wardrobe, trimming its price target from $633 to a more modest $560.

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in March after years of financial woes.